Crossmark Global Holdings’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $362K | Sell |
13,119
-603
| -4% | -$16.6K | 0.01% | 1021 |
|
|
2025
Q1 | $389K | Sell |
13,722
-195
| -1% | -$5.53K | 0.01% | 972 |
|
|
2024
Q4 | $579K | Hold |
13,917
| – | – | 0.01% | 772 |
|
|
2024
Q3 | $930K | Sell |
13,917
-115
| -0.8% | -$7.69K | 0.02% | 637 |
|
|
2024
Q2 | $1.67M | Sell |
14,032
-265
| -2% | -$31.5K | 0.03% | 448 |
|
|
2024
Q1 | $1.52M | Sell |
14,297
-227
| -2% | -$24.2K | 0.03% | 491 |
|
|
2023
Q4 | $1.44M | Sell |
14,524
-273
| -2% | -$27.1K | 0.03% | 490 |
|
|
2023
Q3 | $1.55M | Sell |
14,797
-248
| -2% | -$25.9K | 0.04% | 456 |
|
|
2023
Q2 | $1.79M | Buy |
15,045
+190
| +1% | +$22.5K | 0.04% | 443 |
|
|
2023
Q1 | $2.28M | Sell |
14,855
-629
| -4% | -$96.6K | 0.05% | 370 |
|
|
2022
Q4 | $2.78M | Buy |
15,484
+707
| +5% | +$127K | 0.07% | 308 |
|
|
2022
Q3 | $1.75M | Buy |
14,777
+194
| +1% | +$22.9K | 0.05% | 392 |
|
|
2022
Q2 | $2.08M | Sell |
14,583
-740
| -5% | -$106K | 0.05% | 372 |
|
|
2022
Q1 | $2.64M | Sell |
15,323
-1,280
| -8% | -$221K | 0.06% | 327 |
|
|
2021
Q4 | $4.22M | Buy |
16,603
+730
| +5% | +$185K | 0.09% | 226 |
|
|
2021
Q3 | $6.11M | Buy |
15,873
+13,820
| +673% | +$5.32M | 0.14% | 165 |
|
|
2021
Q2 | $482K | Sell |
2,053
-20
| -1% | -$4.7K | 0.01% | 949 |
|
|
2021
Q1 | $271K | Buy |
2,073
+10
| +0.5% | +$1.31K | 0.01% | 1225 |
|
|
2020
Q4 | $216K | Buy |
+2,063
| New | +$216K | 0.01% | 1274 |
|